Cyclosporine and anti-interleukin 2 receptor monoclonal antibody therapy suppress accelerated rejection of rat cardiac allografts through different effector mechanisms.

Source:http://linkedlifedata.com/resource/pubmed/id/2106180

Download in:

View as

General Info

PMID
2106180